ABSTRACT This study was conducted to identify the effects of 25-OH cholecalciferol supplementation to turkeys on the immune cells parameters, fecal coccidial oocyst shedding, macrophage nitric oxide production, T regulatory cell cytokine production, and production parameters during a coccidial challenge. A total of 200 1-day-old turkey poults were supplemented with 27.5, 55, 82.5, or 110 μg/kg 25-OH cholecalciferol and challenged or not challenged with coccidial oocysts in a 4 × 2 factorial set up of treatments. Birds fed 110 μg/kg of 25-OH cholecalciferol and infected with coccidial oocyst had 41% lower (P < 0.05) fecal oocyst and 53% higher (P < 0.05) macrophage nitric oxide production than the birds fed 27.5 μg/kg of 25-OH cholecalciferol and infected with coccidial oocyst at 5 d post-coccidial infection. Birds fed 82.5 μg/kg 25-OH cholecalciferol and infected with coccidial oocyst had 5-fold higher (P < 0.05) IL-1 mRNA amounts than the birds fed 27.5 μg/kg of 25-OH cholecalciferol and infected with coccidial oocyst. Birds fed 110 μg/kg 25-OH cholecalciferol and infected with coccidial oocyst had 5.3-fold higher (P < 0.05) IL-10 mRNA amounts than the birds fed 27.5 μg/kg of 25-OH cholecalciferol and infected with coccidial oocyst at 5 d post-coccidial infection. CD4 + CD25 + cells from birds fed 110 μg of 25-OH cholecalciferol and infected with coccidial oocyst had 12-fold higher (P < 0.05) IL-10 mRNA than that from the birds fed 27.5 μg/kg of 25-OH cholecalciferol and infected with coccidial oocyst. In conclusion, supplementing birds with 101 μg/kg 25-OH cholicalciferol decreases coccidial oocyst shedding in the feces and could be a nutritional strategy to reduce the coccidial infection and spread in turkeys.
INTRODUCTION
Cholecalciferol is the inactive form of vitamin D and is synthesized in the skin of animals when exposed to ultraviolet light. Cholecalciferol is converted into its active form by 2 enzymes, 25-hydroxylase and 1α-hydroxylase. Liver 25-hydroxylase hydroxylates cholecalciferol to form 25-OH cholecalciferol (van Etten et al., 2008) and kidney 1α-hydroxylase mediates the subsequent hydroxylation of 25-OH cholecalciferol to produce 1, 25-dihydroxycholecalciferol, the active form of vitamin D (Norman, 2008) . Although the kidney is the major organ that expresses 1α-hydroxylase, extra renal expression has been reported in chickens particularly in the breast muscle (Shanmugasundaram and Selvaraj, 2012c) .
Vitamin D plays a major role in modulating immune responses. Active vitamin D can act both in an autocrine and a paracrine manner on immune cells (van Etten et al., 2008) . The effect of vitamin D on immune cells depends on the subtype of immune cells. Monocytes and macrophages constitutively express vitamin D receptor (Wang et al., 2012) , and hence 1, 25-dihydroxycholecalciferol helps maturation of monocytes into macrophages (Di Rosa et al., 2012) and increases the microbicidal activity of macrophages by increasing the production of nitric oxide, antimicrobial proteins, and inflammatory cytokines (Fritsche et al., 2003; Nelson et al., 2011) . Vitamin D in general has been shown to increase the action of innate immune system. On the other hand, vitamin D suppresses the action of adaptive immune responses by inducing T regulatory cells and increasing the production of IL-10. In humans, 1, 25-dihydroxycholecalciferol converts dendritic cells into tolerogenic dendritic cells that had decreased inflammatory cytokine production (Bartels et al., 2010) . Even in cells of innate immunity, there is a bidirectional effect of vitamin D in that monocytes stimulated with LPS, in the presence of 1,25-dihydroxycholecalciferol, though downregulated IL-10 in the first 8 h of LPS stimulation, at 48 h after stimulation, macrophages increased IL-10 expression (Matilainen et al., 2010) . Day-old birds were fed diets supplemented with 25(OH)D at doses of 27.5, 55, 82.5, or 110 μg/kg of feed. At 21 d of age, birds were weighed individually and orally challenged with 20,000 live E. maxima oocysts in a 4 × 2 factorial setup of treatments. At day 5 and 12 coccidial challenge, body weight was measured. Bars (± SEM) without a common superscript differ significantly (P < 0.05).
Coccidial infections produce severe symptoms and mortality in turkeys and cause substantial economic loss for the poultry industry despite available treatments. Birds infected with coccidial parasite combat the infection by mounting an inflammatory response mediated by increased production of nitric oxide and pro-inflammatory cytokines such as IL-1β and IFN-γ (Ovington and Smith, 1992) . However, proinflammatory cytokines induce the release of acute phase proteins to cause anorexia, fever, and decreased growth in animals and result in decreased BW gain. Counteracting the effect of inflammatory cytokines by supplementing vitamin D, especially 25-OH cholecalciferol has been proposed earlier in chickens. Supplementing chickens with 25-OH cholecalciferol decreased the fecal coccidial oocyst load and improved production performances (Morris et al., 2015) .
This study was conducted to identify the effects of 25-OH cholecalciferol supplementation to turkeys on the immune cells parameters, fecal coccidial oocyst shedding, T regulatory cell cytokine production, and production parameters during a coccidial challenge.
MATERIALS AND METHODS
This experiment was conducted to study the effect of 25-OH cholecalciferol supplementation during a coccidiosis challenge. All animal protocols were approved by the Institutional Animal Care and Use Committee at The Ohio State University.
Animals, Housing and Coccidial Infection
A total of 200 1-day-old Hybrid Converter Large White turkeys (Cooper Farms, OH) were randomly distributed to 1 of 4 treatment groups. Each treatment was replicated in 10 (n = 10) individual battery cages with a total of 5 poults in each individual battery cage. All poults were wing tagged and weighed individually. The 4 experimental groups were fed a basal diet (Table 1) supplemented with 25-OH cholecalciferol (HyD, DSM Nutritional Products, Netherlands) at doses of 27.5, 55, 82.5, or 110 μg/kg, which are equivalent to 1,100, 2,200, 3,300, or 4,400 IU of cholecalciferol. At 14 d of age, birds were weighed. Five individual battery cages per treatment were chosen, and all poults in the pen were orally challenged with 20,000 live Eimeria maxima oocysts (Gift from Dr. L. Fuller, The University of Georgia) in 100 μL of PBS to induce a coccidial infection. The poults in the remaining 5 battery cages/treatment were left unchallenged. The experiment was analyzed as a completely randomized design with a 4 × 2 factorial arrangement of treatments, and the unchallenged poults in each treatment group served as the control.
Effect of Different Dose of 25(OH)D on Fecal Coccidia Oocyst Load Post Coccidia Challenge
On day 5 and 12, post-coccidia challenge fecal samples were collected from individual battery cages in air tight plastic bags and stored at 4
• C until further analysis. On the day of analysis, samples were homogenized, and coccidial oocysts were enriched using a salt flotation technique described previously (Levine et al., 1960) . Coccidial oocysts were diluted and counted using the McMaster counting chamber (Chalex Corporation, Ketchum, ID).
Effect of Different Dose of 25(OH)D on Macrophage Nitrite Production
Approximately 10 mL of blood was layered over 5 mL of Histopaque-1077 and centrifuged at 400 × g at 10
• C for 15 min. The cells at the interface were washed and resuspended in complete RPMI-1640 medium (Hahn-Dantona et al., 2000) . Cells, 1 × 10 6 cells/well, were plated in 500 μL of RPMI-1640 medium supplemented with 10% FBS, 1% nonessential amino acids, L-glutamine, and 2% penicillin and streptomycin and allowed to adhere overnight at 37
• C and 5% CO 2 in 48 well plates. Monocytes were stimulated with 0 μg/well of LPS (control) or 0.5 μg/well of Salmonella typhimurium LPS (#L9516, Sigma, St. Louis, MO) for 24 h. Nitrite content of the cell culture supernatant was quantified using Greiss reagent (Ricca Chemical Company, Arlington, TX) following the manufacturer's instructions (Annamalai and Selvaraj, 2012) .
Effect of Different Dose of 25(OH)D on CD4

+
and CD8 + Cell Percentage in Cecal Tonsils Post Coccidia Challenge
One poult was selected randomly from each individual battery cage (n = 5) on day 5 and 12 post-coccidia challenge. Cecal tonsils were collected to determine the percentage of CD4 + and CD8 + cells on day 5 and 12. Single cell suspensions of the cecal tonsils were enriched for the mononuclear cells by density gradient separation as described previously (Shanmugasundaram and Selvaraj, 2012b) . The percentages of CD4 + and CD8 + in the mononuclear cell populations were determined in a flow cytometer as described previously (Shanmugasundaram and Selvaraj, 2012a) .
Effect of Different Dose of 25(OH)D Treatment on IL-1 and IL-10 mRNA Relative Amounts in Cecal Tonsils
At day 5 and 12 post-coccidia challenge, 1 poult was selected randomly from each individual battery cage (n = 5/treatment) and sacrificed. Samples of the cecal tonsils were collected in RNAlater (Qiagen, Valencia). After 24 h, RNAlater was discarded, and the organs were stored at -70
• C until further analysis. Total RNA was extracted from the cecal tonsils using Tri-reagent (Molecular Research Center, Inc., Cincinnati) and reverse transcribed into cDNA. cDNA was analyzed for relative abundance of IL-1β (5 -tcctccagccagaaagtga-3 and 5 -caggcggtagaagatgaagc-3 ) and IL-10 (F 5 -caatccagggacgatgaact-3 and R 5 -ggcaggacctcatctgtgtag-3 ) mRNA relative abundance by quantitative real-time PCR (iCycler, BioRad) using SyBr green after normalizing for β-actin (5 -accggactgttaccaacacc-3 and 5 -gactgctgctgacaccttca-3 ) mRNA relative abundance as described previously (Morris and Selvaraj, 2014) . Annealing temperatures for IL-1β, IL-10, and β-actin primers were 57.5, 55, and 57
• C, respectively. The fold change from the reference was calculated as 2 (Ct Sample) /2 (Ct Reference) , where Ct is the threshold cycle (Selvaraj et al., 2010) . The reference group was the group fed 27.5 μg/kg of 25(OH)D and not challenged with the coccidia parasite. The threshold (Ct) values were determined by iQ5 software (BioRad, Hercules, CA).
Effect of Different Dose of 25(OH)D Treatment on Cecal Tonsil CD4
+ CD25 + Cell Percentages and Relative IL-10 mRNA Amounts Single cell suspensions from the cecal tonsil were enriched for mononuclear cells by density centrifugation over Histopaque (1.077 g/mL, Sigma Aldrich) at 400 × g for 15 min. Cells (1 × 10 6 ) were incubated with 10 μg/mL of PE-conjugated mouse anti-chicken CD25, 10 μg/mL FITC-conjugated mouse anti-chicken CD4 (Southern Biotech, Birmingham, AL), and 1:200 dilution of unlabeled mouse IgG for 45 min. The unbound antibodies were removed by centrifugation. The percentage of CD4 + CD25 + cells in different organs was analyzed in a flow cytometer (Guava Eascyte, Millipore) and expressed as percentage of CD4 + cells. CD4 + CD25 + cells were sorted using the anti-PE multisort kit (#130-090-757, Miltenyi Biotech, Auburn, CA) following the manufacturer's instructions. Single cell suspensions from the cecal tonsils were enriched for mononuclear cells by density centrifugation. Cells (5 × 10 7 cells) were incubated with 20 μg of PE-conjugated anti-chicken CD25 for 45 min and 1:200 dilution of unlabeled mouse IgG in 1 mL of PBS buffer supplemented with 0.5% BSA and 2 mM EDTA (buffer). The unbound antibodies were removed by centrifugation, washed with PBS 2 times, and incubated with 10 μL of anti-PE multisort PE beads in 100 μL of buffer for 15 min. The unbound beads were removed by centrifugation, and CD25 + cells were collected by positive selection in an MS column (Miltenyi Biotech) following the manufacturer's instructions. The multisort beads were removed using the multisort release reagent (Miltenyi Biotech) following the manufacturer's instructions. The CD25 + cells were incubated with 10 μg of APC-conjugated anti-chicken CD4 for 10 min in 100 μL of buffer. The unbound antibodies were removed by centrifugation and incubated with 10 μL of anti-APC conjugated beads (# 130-090-855, Miltenyi Biotech). The unbound beads were removed by centrifugation, and CD4 + CD25 + cells were collected by positive selection in an MS column following the manufacturer's instructions.
Statistical Analysis
Data were analyzed using a 2-way ANOVA to test the interaction effects of 25(OH)D and coccidial infection on dependent variables. When the effects were significant (P < 0.05), differences between means were analyzed by Tukey's least square means comparison (JMP, SAS Institute Inc., Cary, NC).
RESULTS
Effect of 25-OH Cholecalciferol Supplementation on Production Parameters Pre-and Post-Coccidial Challenge
There were no significant interactions between 25-OH cholecalciferol supplementation and coccidial infection on 21 d BWG or BWG at day 5 and 15 post-coccidial infection (P > 0.05; Table 1 ). Coccidial infection decreased the body weight gain (P < 0.05). 
Effect of 25-OH Cholecalciferol Supplementation on Fecal Coccidia Oocyst Load Post Coccidia Challenge
Birds with coccidial infection had higher number of oocyst in the feces compared to birds with no coccidial infection at both day 5 and 12 post-coccidial challenge (Figure 1 ). Within birds infected with coccidial oocyst, birds fed 110 μg of 25-OH cholecalciferol had lower oocyst numbers at both day 5 (P = 0.01) and day 12 (P = 0.29) post-coccidial challenge than birds fed 27.5 μg/kg of 25(OH)D. Birds fed 110 μg/kg of 25-OH cholecalciferol and infected with coccidial oocyst had 41% lower fecal oocyst than the birds fed 27.5 μg/kg of 25-OH cholecalciferol and infected with coccidial oocyst
Effect of 25-OH Cholecalciferol Supplementation on Macrophage Nitric Oxide Production
Within birds infected with coccidial oocyst, macrophages from birds fed 82.5 and 110 μg of 25-OH cholecalciferol had higher nitric oxide production at day 5 (P = 0.01) post-coccidial challenge (Figure 2 ) than birds fed 27.5 μg/kg of 25(OH)D. Macrophages from birds fed 110 μg/kg of 25-OH cholecalciferol and infected with coccidial oocyst had 53% higher nitric oxide production than the birds fed 27.5 μg/kg of 25-OH cholecalciferol and infected with coccidial oocyst at 5 d post-coccidial challenge. 
Effect of 25-OH Cholecalciferol Supplementation on Cecal Tonsil IL-1 mRNA Amounts
Birds with coccidial infection had upregulated IL-1 compared to birds with no coccidial infection at both day 5 and 12 post-coccidial challenge (Figure 3) . Within birds infected with coccidial oocyst, birds fed 82.5 μg/kg 25-OH cholecalciferol had higher IL-1 mRNA amounts at both day 5 (P < 0.01) and 12 (P <0.01) post-coccidial challenge than birds fed 27.5 μg/kg of 25(OH)D. Birds fed 82.5 μg/kg 25-OH cholecalciferol and infected with coccidial oocyst had 5-fold higher IL-1 mRNA amounts than the birds fed 27.5 μg/kg of 25-OH cholecalciferol and infected with coccidial oocyst. At 12 d post-coccidial challenge, birds fed 110 μg/kg 25-OH cholecalciferol had comparable IL-1 mRNA amounts to the birds fed 110 μg/kg 25-OH cholecalciferol with no coccidial challenge.
Effect of 25-OH Cholecalciferol Supplementation on Cecal Tonsil IL-10 mRNA Amounts
Birds with coccidial infection had upregulated IL-10 compared to birds with no coccidial infection at both day 5 and 12 post-coccidial challenge (Figure 4) . Within birds infected with coccidial oocyst, birds fed 55, 82.5, and 110 μg/kg 25-OH cholecalciferol had higher IL-10 mRNA amounts at both day 5 (P < 0.01) and day 12 (P = 0.06) post-coccidial challenge than birds fed 27.5 μg/kg of 25(OH)D. Birds fed 110 μg/kg 25-OH cholecalciferol and infected with coccidial oocyst had 5.3-fold higher IL-10 mRNA amounts than the birds fed 27.5 μg/kg of 25-OH cholecalciferol and infected with coccidial oocyst at 5 d post-coccidial infection. + CD25 + cell percentages were collected and analyzed for IL-10 mRNA. Relative amounts of IL-10 mRNA were measured. IL-10 mRNA content was analyzed after correcting for β-actin mRNA content and normalizing to the mRNA content of the 27.5 ug/kg 25(OH)D and not challenged with coccidiosis, so all bars represent fold change compared to that group. Bars (± SEM) without a common superscript differ significantly (P < 0.05). P values: 25(OH)D, P < 0.01; Cocci, P < 0.01; 25(OH)D × Cocci, P < 0.01.
Effect of Different Dose of 25-OH Cholecalciferol On CD4
+ and CD8
+ Cell Percentage in Cecal Tonsils Post Coccidia Challenge
There were no significant interactions between 25-OH cholecalciferol and coccidal infection on cecal tonsil CD4 + and CD8 + cell percentages at day 5 and 12 postcoccidial infection (P > 0.05).
Effect of 25-OH Cholecalciferol Supplementation on Cecal Tonsil CD4
+ CD25 + Cell Numbers and IL-10 mRNA Amounts There were no significant interactions between 25-OH cholecalciferol and coccidal infection on cecal tonsil CD4 + CD25 + cell numbers at day 12 post infection. 25-OH cholecalciferol supplementation increased (P = 0.03) CD4 + CD25 + cell percentage in the cecal tonsils. Within birds infected with coccidial oocyst, CD4 + CD25 + cells from birds fed 110 μg of 25-OH cholecalciferol had highest amount of IL-10 mRNA amounts at day 12 (P < 0.01) post-coccidial challenge than birds fed 27.5 μg/kg of 25-OH cholecalciferol ( Figure 5 ). CD4 + CD25 + cells from birds fed 110 μg of 25-OH cholecalciferol and infected with coccidial oocyst had 12-fold higher IL-10 mRNA than that from the birds fed 27.5 μg/kg of 25-OH cholecalciferol and infected with coccidial oocyst.
DISCUSSION
This experiment studied the effects of 25-OH cholecalciferol supplementation on turkey production parameters, fecal coccidial oocyst count, and immune parameters following an experimental coccidial infection. 25-OH cholecalciferol supplementation decreased fecal oocyst shedding, increased the macrophage nitric oxide production, and increased cecal tonsil IL-1 and increased IL-10 mRNA content post-coccidial infection.
25-OH cholecalciferol supplementation increased nitric oxide production in turkey macrophages. During coccidial infection, macrophages play a critical role in the host defense mechanism. Macrophages stimulated with cytokine IFN-γ produce nitric oxide and reactive oxygen species that inhibit the growth of pathogenic bacteria and inhibit the replication of E. tenella (Ovington and Smith, 1992) . 1, 25-dihydroxycholecalciferol alone at nanomolar concentration induced nitric oxide production in an HL-60 cell line and inhibited the growth of Mycobacterium tuberculosis in a nitric oxide dependent manner (Rockett et al., 1998) . Chicken HD11 cells treated in vitro with 25-OH cholecalciferol and stimulated with LPS have increased nitric oxide production. The nitric oxide produced in infected hosts mediates a multitude of functions which includes antiviral, proinflammatory, antibacterial, and antiparasitic actions (Karupiah et al., 1993) and can be expected to improve host defense against coccidiosis.
25-OH cholecalciferol supplementation increased IL-1 mRNA amounts in the cecal tonsils. 1, 25-dihydroxycholecalciferol, along with LPS, or the inflammatory cytokine TNF-α, increases the mRNA amounts of IL-1β in a dose-dependent manner by activating Erk1/2 pathway and increasing the phosphorylation of C/EBPβ, a key transcriptional factor for the IL-1β gene. Also 1, 25-dihydroxycholecalciferol in the presence of LPS increased the expression of TLR4 in human macrophages (Di Rosa et al., 2012) . Increased inflammatory cytokines can be expected to improve the host defense against coccidial pathogen. In addition, NF-κB binding sites have been identified in the promoter regions of 1α-hydroxylase enzyme, which converts inactive form of vitamin D to its active form. IL-1 through activating NF-κB, JAK-STAT, and p38 mitogen-activated protein kinase pathways can be expected to induce 1α-hydroxylase mRNA expression in monocytes (Stoffels et al., 2006) and exponentially increase the availability of vitamin D to monocytes. Earlier in chickens, we identified that during inflammation, supplementing 25-OH cholecalciferol increased the concentration of active vitamin D3 in monocytes by upregulating 1α-hydroxylase (Morris and Selvaraj, 2014; Morris et al., 2015) .
25-OH cholecalciferol supplementation increased IL-10 mRNA amounts in turkey T regulatory cells. In humans, 1, 25-dihydroxycholecalciferol supplementation induces tolerogenic dendritic cells characterized by increased anti-inflammatory cytokine and decreased inflammatory cytokine production (Bartels et al., 2010) . Cytokines produced by tolerogenic dendritic cells induce the conversion of naïve CD4 + CD25 − T cells into CD4 + CD25 + T regulatory cells (Penna et al., 2005) . 1,25-dihydroxycholecalciferol inhibited the production of inflammatory cytokines and upregulated the production of IL-10 in CD4 + T cells and CTLA-4 and FoxP3 upregulation in T-regulatory cells (Jeffery et al., 2012) . Though T cells have limited expression of 1α-hydroxylase enzyme, T cells utilize 1,25-dihydroxycholecalciferol production by activated monocytes or dendritic cells in the site of inflammation (Jeffery et al., 2009 ).
In conclusion, 25-OH cholecalciferol supplementation increased the expression of the inflammatory gene IL-1β mRNA post-coccidial challenge and decreased coccidial oocyst shedding and hence it might be beneficial to supplement 25-OH cholecalciferol during coccidial infections.
